Informed by our improved appreciation of the human phenotype caused by germline IKZF2 variants, we suggest that germline heterozygous dominant negative IKZF2 variants should now be considered in the differential diagnosis of patients with AIHA and PIRD. This evidence concerns the gene IKZF2 and autoimmune hemolytic anemia.